42 related articles for article (PubMed ID: 30558966)
1. Morphology combined with
Joyce CM; Maher GJ; Dineen S; Suraweera N; McCarthy TV; Coulter J; O'Donoghue K; Seckl MJ; Fitzgerald B
J Clin Pathol; 2024 Mar; ():. PubMed ID: 38555105
[TBL] [Abstract][Full Text] [Related]
2. Heuristic neural network approach in histological sections detection of hydatidiform mole.
Palee P; Sharp B; Noriega L; Sebire N; Platt C
J Med Imaging (Bellingham); 2019 Oct; 6(4):044501. PubMed ID: 31720313
[TBL] [Abstract][Full Text] [Related]
3. Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease Registry.
Joyce CM; Wakefield C; Chen-Maxwell D; Dineen S; Kenneally C; Downey P; Duffy C; O'Donoghue K; Coulter J; Fitzgerald B
J Clin Pathol; 2024 Mar; ():. PubMed ID: 38555103
[TBL] [Abstract][Full Text] [Related]
4. Hydatidiform mole resulting from sexual violence.
Drezett J; Kurobe FC; Nobumoto CT; Pedroso D; Blake M; Valenti VE; Vanderlei LC; Adami F; Vanderlei FM; de Araujo Moraes SD; Vertamatti MA; Reis AO; de Mello Monteiro CB; Rossi RC; de Abreu LC
Int Arch Med; 2012 Feb; 5():8. PubMed ID: 22353179
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.
Khawajkie Y; Mechtouf N; Nguyen NMP; Rahimi K; Breguet M; Arseneau J; Ronnett BM; Hoffner L; Lazure F; Arnaud M; Peers F; Tan L; Rafea BA; Aguinaga M; Horowitz NS; Ao A; Tan SL; Brown R; Buckett W; Surti U; Hovanes K; Sahoo T; Sauthier P; Slim R
Mod Pathol; 2020 May; 33(5):880-892. PubMed ID: 31857680
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor expression in hydatidiform mole and gestational trophoblastic neoplasia: A cross-sectional study.
Sasotya RS; Kustiandi A; Hidayat YM; Effendi JS; Permadi W; Harsono AB; Mulyantari AI; Hernowo BS
J Taibah Univ Med Sci; 2024 Feb; 19(1):184-189. PubMed ID: 38047239
[TBL] [Abstract][Full Text] [Related]
7. A new cirrhotic animal protocol combining carbon tetrachloride with methotrexate to address limitations of the currently used chemical-induced models.
Mansouri RA; Ahmed AM; Alshaibi HF; Al-Bazi MM; Banjabi AA; Alsufiani HM; Aloqbi AA; Aboubakr EM
Front Pharmacol; 2023; 14():1201583. PubMed ID: 37397479
[No Abstract] [Full Text] [Related]
8. Tubal ectopic twin pregnancy of complete hydatidiform mole and coexisting embryo: A rare case report.
Shen Y; Wang J; Shao Y; Gong C; Zhao R
Medicine (Baltimore); 2023 Jun; 102(22):e33922. PubMed ID: 37266634
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of BCL-2 in hydatidiform moles: a tissue microarray study.
Al-Jabri M; Al-Badi S; Al-Kindi H; Arafa M
Pathologica; 2023 May; 1(1):148-154. PubMed ID: 37216303
[TBL] [Abstract][Full Text] [Related]
10. Advances in immunotherapy and molecular targeted therapy of gestational trophoblastic tumor: current practice and future perspectives.
Chen S; Li T; Meng L; Liu K
Am J Cancer Res; 2022; 12(6):2422-2432. PubMed ID: 35812047
[TBL] [Abstract][Full Text] [Related]
11. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation.
Niu Z; Zhang W; Shi J; Li X; Wu H
J Cardiothorac Surg; 2021 Jul; 16(1):194. PubMed ID: 34233689
[TBL] [Abstract][Full Text] [Related]
12. Hydatidiform mole in a scar on the uterus: A case report.
Jiang HR; Shi WW; Liang X; Zhang H; Tan Y
World J Clin Cases; 2020 Apr; 8(8):1547-1553. PubMed ID: 32368549
[TBL] [Abstract][Full Text] [Related]
13. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion.
Chen Y; Shen D; Gu Y; Zhong P; Xie J; Song Q
Wien Klin Wochenschr; 2012 Mar; 124(5-6):184-7. PubMed ID: 22218717
[TBL] [Abstract][Full Text] [Related]
15. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
16. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.
Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K
Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612
[TBL] [Abstract][Full Text] [Related]
17. Tetraploid partial hydatidiform mole: a case report and review of the literature.
Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
